Lv1
30 积分 2024-07-17 加入
Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease
2天前
已完结
Genomic and evolutionary classification of lung cancer in never smokers
5个月前
已完结
Lung cancer in patients who have never smoked — an emerging disease
5个月前
已完结
Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma
6个月前
已完结
Denosumab for the Treatment of Smoldering Multiple Myeloma: Rates of Osteoporosis and Change in Lowest T-Score after 12 Months of Treatment
6个月前
已关闭
Extending Dosing Intervals of Denosumab As a Maintenance Strategy in Multiple Myeloma: A Real-World Experience at a Large Academic Cancer Center
6个月前
已关闭
Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
6个月前
已完结
Controversies in the use of new bone‐modifying therapies in multiple myeloma
6个月前
已完结
Denosumab vs Zoledronic Acid for Bone-Targeted Therapy in Multiple Myeloma
6个月前
已完结
Prevention of Skeletal-Related Events With Extended-Interval Denosumab: A Review of the Literature
6个月前
已完结
皖公网安备34019202002308
